National Institutes Of Health
-
Cell and Developmental Biology pushes the limits of cancer research
If you had visited Vanderbilt nearly a century ago searching for cellular research, you would have found yourself in the Department of Anatomy. Established in 1925, the Department of Anatomy gave way to the Department of Cell Biology before taking on its current moniker—Cell and Developmental Biology—in 2001. Read MoreMar. 7, 2024
-
Vanderbilt biochemists discover breakthrough evolution-resistant compound to combat antibiotic resistance
The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read MoreFeb. 26, 2024
-
First successful clinical trial of VU319 brings Alzheimer’s treatment one step closer
Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read MoreJan. 19, 2024
-
Biomedical Ph.D. alumni career goals and outcomes revealed in new research
New research from the Office of Biomedical Research Education and Training connects the dots between career goals during graduate school and career outcomes, articulates how careers of Ph.D. alumni evolve during the 10 years after graduation. Read MoreOct. 24, 2023